trending Market Intelligence /marketintelligence/en/news-insights/trending/RnwD3OXXAGTSW0cjAYD9XQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Permira-backed Corin to buy Omni Orthopaedics

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery

Permira-backed Corin to buy Omni Orthopaedics

Corin Group PLC entered into a binding agreement to buy Omni Orthopaedics Inc. in a transaction that is set to close by early March.

Corin is a U.K.-based orthopedic company backed by global investment firm Permira. Omni is a U.S.-based designer, developer and manufacturer of medical devices for the orthopedic industry, with expertise in robotic-assisted knee replacement.

KPMG LLP provided financial and tax advice to Corin, while Barclays Bank PLC provided strategic advice and Skadden Arps Slate Meagher & Flom LLP provided legal advice. Piper Jaffray & Co. was Omni's financial adviser, while Foley Hoag LLP was its legal adviser.